top of page

Deborah Bondi

PharmD, FCCP, FPPA, BCPS, BCPPS

Rotations

PGY-1 Pediatric Selective (Neonatal ICU), PGY-2 Pediatric Neonatal ICU, PGY-2 Pediatric Nutrition

Education

PharmD: University of Missouri - Kansas City

Residency Training

PGY-1: University of Illinois at Chicago
PGY-2 Pediatrics: University of Illinois at Chicago

Deborah Bondi

Practice Interests

Neonatology, Residency Training; Diversity, Equity, and Inclusion (DEI)

Professional Affiliation


American College of Clinical Pharmacy (ACCP):      

  • Inducted as Fellow (2021)

  • Board of Regents (2024-Present)

  • Task Force on Diversity, Equity, and Inclusion (2022-2024)

  • Faculty for the Preparatory Review and Recertification Course (2017-Present)

  • Chair of the Clinical Practice Affairs Committee (2021-2022) 

  • Chair of the Pediatric PRN (2020-2021)

  • Vice-Chair of the Clinical Practice Affairs Committee (2020-2021)

  • Chair-Elect of the Pediatric PRN (2019-2020)

  • Vice-Chair of the Certification Affairs Committee (2019-2020)

  • Clinical Practice Affairs Committee (2018-2019)

  • Organizational Affairs Committee (2017-2018)


Pediatric Pharmacy Association (PPA):

  • Diversity, Equity, and Inclusion Committee (2022-Present)

  • Chair of the Research Committee (2023-2024)

  • Vice-Chair of the Research Committee (2022-2023)

  • Chair of the Neonatal Special Interest Group (SIG) (2021-2023)

  • Vice-Chair of the Neonatal SIG (2020-2021)

Recent Publications

  • Khawaja H, Sanders TA, Schreiber MD, Bondi DS, Shah PA, Brennan GM. Sildenafil as bridge therapy for inhaled nitric oxide in preterm neonates. J Pediatr Pharmacol Ther. In Press. (Accepted May 2023).

  • Bondi DS, Szwak JA, Rech MA. An aspirational research model and the difficulties of implementation in the current fiscal and training landscape. J Am Coll Clin Pharm. 2024;7(7):616-618.

  • Songer CN, Bondi DS, Oliveri LM, Jarrett JB, Ohler KH. Survey of pediatric pharmacy residency program directors and former residents on post-graduate training paths survey of pediatric post-graduate training paths. J Pediatr Pharmacol Ther. 2023;28(6):530-539. doi: 10.5863/1551-6776-28.6.530.

  • Wilson GA, Bondi DS, Shah PA, Nelson A, Kumar M, Bhagat P. Neonatal serum gentamicin concentrations and outcomes following maternal once-daily gentamicin dosing. J Pediatr Pharmacol Ther. 2023;28(4):316-322. doi.org/10.5863/1551-6776-28.4.316

  • Bondi DS, Acquisto NM, Buckley MS, Erdman G, Kerns ST, et al. ACCP White Paper: Rewards, recognition, and advancement for clinical pharmacists. J Am Coll Clin Pharm. 2023;6(4): 427-439. doi:10.1002/jac5.1775

  • Kleespies MS, Shah PA, Bondi DS. Use of calcitonin for hypercalcemia in a premature neonate with congenital mesoblastic nephroma. J Pediatr Pharmacol Ther. 2022;27(7):682-686. doi: 10.5863/1551-6776-27.7.682

  • Galura G, Said SJ, Shah PA, Hissong AM, Chokshi NK, Fauman KR, Rose R, Bondi DS. Comparison of extracorporeal life support anticoagulation utilizing activated clotting time only to a multimodal approach in pediatric patients. J Pediatr Pharmacol Ther. 2022;27(6):517-523. doi: 10.5863/1551-6776-27.6.517

  • Beckman EJ, Hovey S, Bondi DS, Patel G, Parrish RH. Pediatric perioperative clinical pharmacy practice: clinical considerations and management: an opinion of the Pediatrics and Perioperative Care Practice and Research Networks of the American College of Clinical Pharmacy. J Pediatr Pharmacol Ther. 2022;27(6):490-505. doi: 10.5863/1551-6776-27.6.490

  • Naveed M, Bondi DS, Shah PA. Dexmedetomidine versus fentanyl for neonates with hypoxic ischemic encephalopathy undergoing therapeutic hypothermia. J Pediatr Pharmacol Ther. 2022;27(4):352-357. doi: 10.5863/1551-6776-27.4.352

  • Hussain WA, Bondi DS, Shah P, Morgan SE, Sriram S, Schreiber M. Implementation of an inhaled nitric oxide weaning protocol and stewardship in a level IV NICU to decrease inappropriate use. J Pediatr Pharmacol Ther. 2022;27(3):234-291. doi: 10.5863/1551-6776-27.3.284

  • Rhodes JAM, Bondi DS, Celmins L, Hope C, Knoebel R. Quality improvement and reconciliation process for automated dispensing cabinet medication overrides. Am J Health-System Pharm. 2022;79(4):306-313. doi: 10.1093/ajhp/zxab406

  • Bondi DS, Alavandi P, Allen J, Avery L, Buatois E, et al. ACCP Commentary: Addressing challenges of providing remote inpatient clinical pharmacy services. J Am Coll Clin Pharm. 2021;4(12):1594-1600. doi: 10.1002/jac5.1553.

  • Pan I, Shah PA, Singh J, Kelly KN, Bondi DS. Comparison of neonatal outcomes with and without prophylaxis with indomethacin in premature neonates. J Pediatr Pharmacol Ther. 2021;26(5):478-483. doi: 10.5863/1551-6776-26.5.478

  • Hornik CD, Bondi DS, Green NM, Cober MP, John B. Review of fluconazole treatment and prophylaxis for invasive candidiasis in neonates. J Pediatric Pharmacol Ther. 2021;26(2):115-122. doi: 10.5863/1551-6776-26.2.115

  • Weaver KL, Bondi DS, Shah PA, Bhagat PH. Evaluation of appropriateness and cost-savings of pharmacist-driven palivizumab ordering. J Pediatr Pharmacol Ther. 2020;25(7): 636-641. doi: 10.5863/1551-6776-25.7.636

  • Ohler KH, Bondi DS. Letter to the Editor: Which PGY1 pharmacy residency is right for me? Advantages and disadvantages of pediatric-focused and traditional PGY1 pharmacy programs. J Pediatr Pharmacol Ther. 2020;25(6):559-561. doi: 10.5863/1551-6776-25.6.559

  • Szwak JA, Bondi DS, Knoebel R, Soni HP. Utility of clinical-focused mini interview during post-graduate year-1 pharmacy residency interviews. J Am Coll Clin Pharm. 2020;3:764–770. doi: 10.1002/jac5.1235 

  • Stranges PM, Jackevicius CA, Anderson SL, Bondi D, Danelich I, et al. ACCP White Paper: Role of clinical pharmacists and pharmacy support personnel in transitions of care. J Am Coll Clin Pharm. 2020;3:532-545. doi: 10.1002/jac5.1215

  • Patel PD, Bhagat P, Bartlett AH, Bondi DS. Comparison of neonatal outcomes with the use cefotaxime versus ceftazidime in a neonatal intensive care unit. J Pediatr Pharmacol Ther. 2020;25(2):117-123. doi: 10.5863/1551-6776-25.2.117

  • Shenk EE, Bondi DS, Pellerite MM, Sriram S. Evaluation of timing and dosing of caffeine citrate in preterm neonates for the prevention of bronchopulmonary dysplasia. J Pediatr Pharmacol Ther. 2018;23(2):139-145. doi: 10.5863/1551-6776-23.2.139

  • Bondi DS, Ohler KH. Vasopressin and hemodynamic effects on the neonate. Neoreviews. 2017;18(8):e460-e471. doi: 10.1542/neo.18-8-e460

  • Saseen JS, Ripley TL, Bondi DS, Burke JM, Cohen LJ, et al. ACCP Guideline: ACCP clinical pharmacist competencies. Pharmacotherapy. 2017;37(5):630-636. doi: 10.1002/phar.1923

  • Welsh K, Bondi DS, Frost B. Probiotics for prevention of necrotizing enterocolitis in neonates. Neoreviews. 2016;17(7):e377-e385. doi 10.1542/neo.17-7-e377

  • Bondi DS, Khan OA, Hageman JR. Maternal selective serotonin reuptake inhibitor use and neurologic effects on the neonate. Neoreviews. 2016;17(7):e356-e366. doi: 10.1542/neo.17-7-e356

  • Raithel DS, Ohler KH, Porto I, Bicknese AR, Kraus DM. Morphine: an effective abortive therapy for pediatric paroxysmal sympathetic hyperactivity after hypoxic brain injury. J Pediatr Pharmacol Ther. 2015;20(4):335-340. doi: 10.5863/1551-6776-20.4.335

Academic and/or National Presentations

  • “The Great Attrition: Principles to Enhance and Promote Longevity in Clinical Pharmacy.” ACPE-Accredited. American College of Clinical Pharmacy Annual Meeting. Phoenix, AZ. Oct. 2024.

  • “Impact of Discrimination and Microaggressions in Pediatric Pharmacy: A Panel Discussion.” ACPE-Accredited. Pediatric Pharmacy Association Annual Meeting. Minneapolis, MN. May 2024.

  • “2023 Critical Care Year in Review.” ACPE-Accredited. Pediatric Pharmacy Association Webinar. Virtual. Dec. 2023.

  • “What is the Precedent for Precedex for Neonatal Encephalopathy?” ACPE-Accredited. Pediatric Pharmacy Association Annual Meeting: Norfolk, VA. May 2022.

  • “NICU Literature: 2021 Year in Review.” ACPE-Accredited. Pediatric Pharmacy Association Annual Meeting: Norfolk, VA. May 2022.

  • “COVID vaccination in children.” ACPE-Accredited. American College of Clinical Pharmacy 2021 Updates Plus in Pediatric Pharmacy Webinar. Virtual. May 2022.

  • “Pediatrics.” ACPE-Accredited. American College of Clinical Pharmacy Updates in Therapeutics®: Pharmacotherapy Preparatory Review and Recertification Course: Annual Presentation at Rotating Locations. Apr. 2022. [Previous presentations: Feb. 2018, Apr. 2019, Apr. 2020, Apr. 2021].

  • “Feeling Hot and Cold After Pediatric Emergencies: Hot and Cold Debriefing with Pharmacy Learners.” ACPE-Accredited. Pediatric Pharmacy Association Fall Conference: Virtual Meeting. Sep. 2020.

  • “Inhaled Nitric Oxide Stewardship in the Neonatal Intensive Care Unit.” ACPE-Accredited. Pediatric Pharmacy Association Annual Meeting: Virtual Meeting. May 2020.

  • “Don’t Be So Shocked! Updates from the American College of Critical Care Medicine on the Management of Pediatric and Neonatal Shock.” ACPE-Accredited. Pediatric Pharmacy Advocacy Group Annual Meeting: Salt Lake City, UT. Apr. 2018.

    International/National Invited Panel/Roundtable Member or Non-Continuing Education Lectures

  • “RSV Prevention in Pediatric Patients.” Vizient Center for Pharmacy Practice Excellence Forum. Virtual. Oct. 2023.

  • “Pharmacy Practice in the United States.” Korean Pharmacy Student’s Association. Seoul, South Korea. Sep. 2023.

  • “Persistent Pulmonary Hypertension of the Newborn.” Pediatric Pharmacy Association Core Competency Programming. Virtual. Jul. 2022.

  • “Acquiring Letters of Recommendation: Best Practices.” American College of Clinical Pharmacy. Virtual. April 2023.

  • "Resident/Fellow Panel Discussion.” American College of Clinical Pharmacy. Virtual. Mar. 2022.

  • "Pediatric Subspecialty Virtual Roundtables.” Round-Table Panel Discussion Moderator. Pediatric Pharmacy Association. Virtual. Dec. 2021.

  • "Gender Equality: The Era of Hashtags.” Round-Table Panel Discussion. Pediatric Pharmacy Association Annual Meeting: Virtual. Apr. 2021.

  • AAP 2023 Critical Care Year in Review. ACPE-Accredited. Pediatric Pharmacy Association Webinar. Virtual. Dec. 2023

  • "Persistent Pulmonary Hypertension of the Newborn." ACPE-Accredited. Pediatric Pharmacy Association Core Competency Programming. Virtual. Jul. 2022. 

  • "What is the Precedent for Precedex for Neonatal Encephalopathy?" ACPE-Accredited. Pediatric Pharmacy Association Annual Meeting: Norfolk, VA. May 2022. 

  • "NICU Literature: 2021 Year in Review." ACPE-Accredited. Pediatric Pharmacy Association Annual Meeting: Norfolk, VA. May 2022. 

  • "COVID vaccination in children." ACPE-Accredited. American College of Clinical Pharmacy 2021 Updates Plus in Pediatric Pharmacy Webinar. Virtual. May 2022. 

  • "Pediatrics." ACPE-Accredited. American College of Clinical Pharmacy Updates in Therapeutics: Pharmacotherapy Preparatory Review and Recertification Course: Annual Presentation at Rotating Locations. Apr. 2022. [Previous presentations: Feb. 2018, Apr. 2019, Apr. 2020, Apr. 2021]. 

  • "Feeling Hot and Cold After Pediatric Emergencies: Hot and Cold Debriefing with Pharmacy Learners." ACPE-Accredited. Pediatric Pharmacy Association Fall Conference: Virtual Meeting. Sep. 2020. 

  • "Inhaled Nitric Oxide Stewardship in the Neonatal Intensive Care Unit." ACPE-Accredited. Pediatric Pharmacy Association Annual Meeting: Virtual Meeting. May 2020. 

  • "Don't Be So Shocked! Updates from the American College of Critical Care Medicine on the Management of Pediatric and Neonatal Shock." ACPE-Accredited. Pediatric Pharmacy Advocacy Group Annual Meeting: Salt Lake City, UT. Apr. 2018.

Current Research

  • Evaluation of combination therapy with acetaminophen and non-steroidal anti-inflammatory drugs (NSAID) versus NSAID monotherapy for treatment of patent ductus arteriosus closure in preterm neonates

  • Comparison of midazolam versus dexmedetomidine as second line sedation in very low birth weight neonates

bottom of page